Revenue: The sum of all revenue fields included for a company's operating activities.
AnaptysBio, Inc. (ANAB) had Revenue of $27.77M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$27.77M |
$-39.33M |
|
-- |
|
$27.77M |
|
$55.31M |
|
$-27.54M |
|
$-11.75M |
|
$-39.28M |
|
$-39.28M |
|
$-39.33M |
|
$-39.33M |
|
$-39.33M |
|
$-39.33M |
|
$-27.54M |
|
$-28.60M |
|
30.64M |
|
30.64M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$363.11M |
|
$1.74M |
|
$58.94M |
|
$422.05M |
|
$44.04M |
|
-- |
|
$344.00M |
|
$388.03M |
|
$34.02M |
|
$34.02M |
|
$34.02M |
|
30.39M |
|
| Cash Flow Statement Financials | |
$-10.70M |
|
$14.85M |
|
$-28.59M |
|
$123.08M |
|
$98.64M |
|
$-24.44M |
|
$9.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-99.16% |
|
-99.16% |
|
-- |
|
-141.46% |
|
-141.62% |
|
$-10.73M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.55 |
|
57.96 |
|
-115.60% |
|
-115.60% |
|
-9.32% |
|
-115.60% |
|
$1.12 |
|
$-0.35 |
|
$-0.35 |
|